Virtus Fund Advisers’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$390K Sell
1,605
-136
-8% -$30.9K ﹤0.01% 365
2017
Q3
$352K Sell
1,741
-108
-6% -$21.2K ﹤0.01% 330
2017
Q2
$379K Sell
1,849
-768
-29% -$153K ﹤0.01% 343
2017
Q1
$478K Sell
2,617
-169
-6% -$29.5K ﹤0.01% 327
2016
Q4
$447K Hold
2,786
﹤0.01% 349
2016
Q3
$393K Hold
2,786
﹤0.01% 364
2016
Q2
$382K Hold
2,786
﹤0.01% 366
2016
Q1
$377K Buy
+2,786
New +$377K ﹤0.01% 369
2014
Q3
Sell
-1,497
Closed -$140K 1290
2014
Q2
$140K Buy
+1,497
New +$133K ﹤0.01% 1169

Other funds holding CHE

Virtus Fund Advisers's CHE Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Chemed (CHE) stake by 7.8% in Q4 2017, selling an estimated $30.9K and leaving 1,605 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Virtus Fund Advisers first reported a position in CHE in Q2 2014 and has held it in 9 quarters since. The position peaked at $478K in Q1 2017. 299 funds tracked by Wall St. Rank hold CHE as of Q4 2017.

  • Virtus Fund Advisers held 1,605 shares of Chemed worth $390K as of Q4 2017.
  • Virtus Fund Advisers sold 136 Chemed shares in Q4 2017, an estimated $30.9K.
  • Chemed made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #365 holding.
  • Virtus Fund Advisers first reported a position in Chemed in Q2 2014 and has held it in 9 quarters since.
  • Virtus Fund Advisers's Chemed position peaked at $478K in Q1 2017.
  • 299 funds tracked by Wall St. Rank held Chemed as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.